Management for BI-RADS category 3 lesions detected in preoperative breast MR imaging of breast cancer patients.

Hye Mi GweonNariya ChoSoo-Yeon KimHye Ryoung KooMirinae SeoAjung ChuEun Ju Son

Published in: European radiology (2017)

• BI-RADS category 3 lesions on preoperative MRI had 0.8% malignancy rate. • All cancer diagnoses from BI-RADS 3 occurred after 24-month follow-up. • Annual follow-up might be adequate for BI-RADS 3 detected on preoperative MRI.

Keyphrases

contrast enhanced
patients undergoing
magnetic resonance imaging
papillary thyroid
computed tomography
squamous cell carcinoma
squamous cell
lymph node metastasis